David Lligé
Impact in
- Immunology top 5%
- T-cell and B-cell Immunology
- IL-33, ST2, and ILC Pathways
- Immunodeficiency and Autoimmune Disorders
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune cells in cancer
Papers in
-
- T-cell and B-cell Immunology 2
- IL-33, ST2, and ILC Pathways 1
-
- Glycogen Storage Diseases and Myoclonus 2
- Co-authors
- Arthur Mortha (1 shared paper)Manel Juan (1 shared paper)Sidonia Fagarasan (1 shared paper)Miriam Mérad (1 shared paper)Sergi Serrano (1 shared paper)Aleksey Chudnovskiy (1 shared paper)Montserrat Cols (1 shared paper)Linda Cassis (1 shared paper)
- Journals
- Nature Communications (2 papers)FEBS Letters (1 paper)Nature Immunology (1 paper)European Journal of Clinical Investigation (1 paper)Cell Communication and Signaling (1 paper)
- Partner nations
- SpainJapanUnited States
In The Last Decade
David Lligé
11 papers receiving 578 citations
Peers
Comparison fields: 5 of 64
- Immunology 323
- Virology 11
- Rheumatology 28
- Molecular Biology 118
- Genetics 14
Countries citing papers authored by David Lligé
This map shows the geographic impact of David Lligé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Lligé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Lligé more than expected).
Fields of papers citing papers by David Lligé
This network shows the impact of papers produced by David Lligé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Lligé. The network helps show where David Lligé may publish in the future.
Co-authors
The 25 scholars most cited alongside David Lligé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 245 | |
| 2 | 2017 | 158 | |
| 3 | 2017 | 55 | |
| 4 | 2019 | 35 | |
| 5 | 2005 | 32 | |
| 6 | 2018 | 27 | |
| 7 | 2019 | 14 | |
| 8 | 2005 | 12 | |
| 9 | 2007 | 2 | |
| 10 | 2020 | 2 | |
| 11 | 2007 | 1 |
About David Lligé
David Lligé is a scholar working on Immunology, Rheumatology, Otorhinolaryngology, Genetics and Pulmonary and Respiratory Medicine, having authored 11 papers that have together received 583 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (2 papers), T-cell and B-cell Immunology (2 papers), Glycogen Storage Diseases and Myoclonus (2 papers), Chronic Lymphocytic Leukemia Research (1 paper), Mitochondrial Function and Pathology (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper), Head and Neck Cancer Studies (1 paper) and IL-33, ST2, and ILC Pathways (1 paper). The work is most often cited by research in Immunology (323 citations), Virology (11 citations), Rheumatology (28 citations), Molecular Biology (118 citations) and Genetics (14 citations). David Lligé has collaborated with scholars based in Spain, Japan and United States. Frequent co-authors include Arthur Mortha, Manel Juan, Sidonia Fagarasan, Miriam Mérad, Sergi Serrano, Aleksey Chudnovskiy, Montserrat Cols, Linda Cassis, Giuliana Magri and Laura Comerma. Their work appears in journals such as Nature Communications, FEBS Letters, Nature Immunology, European Journal of Clinical Investigation and Cell Communication and Signaling.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.